Market Snapshot
New York — The Dow Jones Industrial Average has been edging higher in early 2026, but three heavyweight names are pulling on the benchmark. As of Feb. 18, 2026, the Dow had gained about 3.4% year-to-date, while Salesforce (CRM), Microsoft (MSFT) and UnitedHealth Group (UNH) logged double-digit declines.
The divergence underscores a market that is rotating between growth narratives and high-cost bets while policymakers, regulators, and earnings signals mingle with inflation and interest-rate expectations.
- Dow Jones Industrial Average: +3.4% YTD through Feb 18, 2026
- CRM: -29.1% YTD
- MSFT: -17.4% YTD
- UNH: -12.7% YTD
- Top winners in the period: HON +23%, CVX +19%
The Dow’s Biggest Losers 2026: CRM, MSFT, UNH
The trio at the center of the pullback represents very different bets that investors are re-evaluating as 2026 unfolds.
Salesforce CRS: AI Push Meets Profit Roadblock
Salesforce reported fiscal Q3 revenue of about $10.26 billion, roughly in line with equity estimates, while earnings per share came in near consensus. Yet the stock slid as investors weighed the pace of revenue growth against a broader push to turn AI-driven offerings into meaningful profitability.
Analysts cite a transition period as CRM integrates more AI features into its core platforms and faces longer paths to margin expansion. The market is watching for evidence that Salesforce can translate expansion into durable free cash flow, even as investment in new AI tooling remains robust.
Microsoft: Capex Surge, Slowing Free Cash Flow
Microsoft’s quarterly cadence showed an 89% jump in capital expenditures in the latest quarter, clocking in at roughly $29.9 billion. Free cash flow fell about 9.3% year over year, even as Azure cloud revenue grew around 39% and the company continued to deploy capital into data centers and services.
The stock’s decline reflects investor concerns that rising cloud spend and AI investments may weigh on near-term cash generation, even as the company remains a core engine of the market’s technology and enterprise software complex.
UnitedHealth: Regulatory Pressure, Higher Costs Hit Margins
UnitedHealth’s operating income plunged 95% year over year to about $380 million from $7.8 billion as Medicare Advantage faced regulatory pressure and higher medical costs bit into profitability. The drop has fed questions about how quickly the health insurer can restore earnings momentum amid policy scrutiny and cost dynamics.
While UNH maintains scale and a broad member base, investors are weighing the potential for regulatory changes that could constrain preferred-profitability levers, alongside cost pressures that are common in the sector.
What Traders Are Saying
Market participants emphasize a cautious stance as the year begins. While the Dow benefits from strength in energy, materials, and certain industrials, the laggards cast doubt on a broad-based recovery in technology and health care equities.
“Investors are recalibrating growth assumptions for AI leaders and health insurers,” said Maya Chen, senior equities strategist at NorthBridge Capital. “The focus is on whether these companies can translate ambitious product roadmaps into faster cash generation.”
“The dow’s biggest losers 2026 narrative isn’t about a single factor, but a mix of policy risk, margin pressure and investment cycles,” added Kai Nakamura, head of global equities at Riverside Asset Management. “Outlook hinges on how quickly earnings power can be restored as these secular themes evolve.”
Why This Is Happening
The market narrative in 2026 is a tug of war between aggressive investment in AI-powered platforms and the need to demonstrate durable profitability. CRM, MSFT and UNH each face a distinct set of headwinds: CRM's margin path, MSFT’s capex-heavy growth strategy, and UNH’s regulatory and cost pressures. A market that rewards short-term resilience may still punish stocks that trade at premium valuations if operating leverage stays muted.
Sector and Market Context
Beyond the three laggards, other parts of the market have posted solid gains, with consumer staples and energy names helping cushion the broader index. Investors are also watching macro signals—inflation prints, wage data, and the trajectory of interest rates—that will shape how aggressively companies can reaccelerate earnings growth.
The art of 2026 investing appears to be selecting pockets of resilience while avoiding overexposure to sectors with stretched valuations or fragile margin dynamics. The performance gap between the Dow’s big winners and losers remains pronounced, a reminder that the market can rally on one hand while certain giants stumble on the other.
What’s Next
Traders will closely monitor quarterly results and forward guidance from CRM, MSFT, and UNH as a gauge for how much of the 2026 rally depends on cost control, pricing power, and new product adoption. Investors will also parse policy developments around Medicare Advantage and cloud computing regulations for hints about potential earnings trajectories.
For now, the focus remains on the big question: can the dow’s biggest losers 2026 regain momentum, or will the market re-rate these names as the year evolves? The answer will shape whether the Dow can sustain a broader rally or remain a ledger of divergent performance within a mixed earnings environment.
Bottom Line
The Dow’s biggest losers 2026 — CRM, MSFT and UNH — have drawn outsized attention because they sit at the nexus of growth, profitability and policy risk. Their performance matters not just for the index, but for sentiment around the broader market’s ability to turn ambitious AI and health care plans into reliable shareholder value.
As 2026 unfolds, investors will weigh the benefits of resilient franchises against the cost of continuing investments in AI and health care reform. The road ahead may be bumpy, but the ongoing tussle between upside potential and margin discipline will likely define the next phase of the Dow’s bigger and smaller players alike.
Discussion